Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cryoport Inc CYRX

Consumer Cyclical Technology Scientific & Technical Instruments Industrials
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its... see more

Recent & Breaking News (NDAQ:CYRX)

Cryoport Revenue Up 52% for the Second Quarter of 2017, Driven by Biopharma

PR Newswire August 8, 2017

Investor Network: Cryoport, Inc. to Host Earnings Call

Accesswire August 8, 2017

Cryoport to Support Launch of Potential Treatment for Relapsed/Refractory Acute Lymphoblastic Leukemia

PR Newswire July 25, 2017

Cryoport to Report Second Quarter 2017 Financial Results on August 8th, 2017

PR Newswire July 24, 2017

Cryoport Continues to Strengthen Sales Team with Appointments of Colin Coffua as Vice President, Strategic Accounts and John Phillips as Executive Director, Consulting Services

PR Newswire July 13, 2017

Cryoport Biotech Activity Index "CoBRA Index" increases 30.1% in Q1 2017

PR Newswire June 19, 2017

Cryoport Expands Agreement with Sanaria to Support Grant Awards with U.S. National Institutes of Health and U.S. Army

PR Newswire June 7, 2017

Cryoport Revenue Grows by 74%, Driven by Biopharma

PR Newswire May 4, 2017

Investor Network: Cryoport, Inc. to Host Earnings Call

Accesswire May 4, 2017

Cryoport to Report First Quarter 2017 Financial Results on May 4th, 2017

PR Newswire April 24, 2017

Mid-Day Market Update: Exeter Gains On Acquisition News; CryoPort Shares Slide

Benzinga.com  March 28, 2017

Mid-Morning Market Update: Markets Rise; Carnival Profit Beats Estimates

Benzinga.com  March 28, 2017

Cryoport Announces Pricing of Public Offering of Common Stock

PR Newswire March 28, 2017

Cryoport Announces Proposed Public Offering of Common Stock

PR Newswire March 27, 2017

Cryoport Revenue Continues to Climb, Reporting 53% Growth for the Quarter Ended December 31, 2016

PR Newswire March 13, 2017

Cryoport to Report Financial Results for the Three and Nine Months Ended December 31, 2016 on March 13th, 2017

PR Newswire March 2, 2017

Cryoport Introduces CryoStork Next Flight Out Cryogenic Logistics Solution for the Reproductive Health Market

PR Newswire March 1, 2017

Cryoport Launches the "CoBRA Index" for a Comprehensive Measure of Activity in the Regenerative Therapy Space

PR Newswire February 28, 2017

Cryoport to Support ProMab Biotechnologies' CAR-T Cell Preclinical Services

PR Newswire January 17, 2017

Cryoport Supports Gradalis' Vigil® Platform in Clinical Trials for Autologous Immunotherapies for Multiple Cancers

PR Newswire January 3, 2017